News

We provide the latest news
from the world of economics and finance

02 April
Paychex (PAYX) Q3 Earnings Beat Estimates, Revenues Miss

Paychex, Inc. PAYX has reported mixed third-quarter fiscal 2024 results, wherein earnings beat the Zacks Consensus Estimate but revenues missed the same.

PAYX’s earnings of $1.38 per share beat the Zacks Consensus Estimate by 1.5% and increased 7% from the year-ago quarter. Total revenues of $1.4 billion missed the consensus estimate by 1.4% but increased 4.2% from the year-ago quarter.

Quarter in Detail

Revenues from the Management Solutions segment increased 2% year over year to $1 billion, missing our estimate by a slight margin. Professional employer organization (“PEO”) and Insurance Solutions’ revenues totaled $345.5 million, up 8% from the year-ago quarter. The figure missed our estimate of $349.6 million.

Paychex, Inc. Price, Consensus and EPS Surprise

Service revenues of $1.4 billion moved up 4% from the year-ago quarter, missing our estimate by a slight margin. Interest on funds held for clients increased 25% year over year to $43.9 million, surpassing our estimate of $35.6 million.

EBITDA of $694.6 million increased 6% from the year-ago quarter and surpassed our estimate of $691.8 million. Operating income increased 6% year over year to $649.8 million, beating our estimate of $642.4 million. The operating margin was 45.1%, up 80 basis points from the year-ago quarter. It surpassed our anticipation of 44%.

Balance Sheet & Cash Flow

Paychex exited the quarter with cash and cash equivalents of $1.7 billion compared with $1.4 billion at the end of the preceding quarter. The long-term debt totaled $798.5 million compared with $798.4 million in second-quarter fiscal 2024.

Cash generated from operating activities amounted to $671.7 million, while capital expenditure totaled $40.7 million

2024 Guidance

PAYX has reaffirmed its adjusted EPS guidance for fiscal 2024. Adjusted EPS is expected to grow 10-11% year over year. The company expects total revenues to rise 5-6% compared with 6-7% growth mentioned previously.

Management Solutions’ revenues are expected to increase 3.5-4% year over year compared with the 5-6% rise mentioned previously. The company anticipates PEO and Insurance Solutions’ revenues to grow 7-9%. It expects Interest on funds held for clients to be $140-$150 million. The operating margin is projected at 41-42%.

Currently, Paychex carries a Zacks Rank #4 (Sell).

Earnings Snapshots of Peers

FTI Consulting, Inc. FCN reported better-than-expected fourth-quarter 2023 results.

FCN’s earnings per share of $2.28 surpassed the Zacks Consensus Estimate by 45.2% and increased 50% on a year-over-year basis. Total revenues of $924.7 million beat the consensus mark by 11.5% and increased 19.4% from the year-ago quarter.

TransUnion TRU reported impressive fourth-quarter 2023 results.

TRU’s EPS of 70 cents per share (adjusting 67 cents from non-recurring items) surpassed the consensus mark by 14.8% in the fourth quarter and was flat on a year-over-year basis. Total revenues of $954.3 million surpassed the consensus mark by 3% and increased 5.8% year over year on a reported basis. Revenues rose 5% on a constant-currency basis, mainly driven by strength in the international markets.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.